The University of Toledo

Center for Clinical Research : Active Hematology protocols         Study number links to NCI protocol site

Skip to menu | Skip to content | Skip to search | Skip to global navigation
  • Home
  • About UT
  • Directions/Maps
  • Campus Directory
  • Contact
  • myUT
  • Advanced Search
  • Text Only
  • Feedback
  • Prospective Students
  • Admission
  • Academics
  • Campus Life
  • Current Students
  • Faculty & Staff
  • Research
  • Athletics
  • Alumni & Community
  • Print
Center for Clinical Research
  • No top menu
    • <!-- no script -->
    Select an Organ Site
    • Brain
    • Breast
    • Genitourinary
    • GI
    • GYN
    • Hematology
    • Melanoma
    • Cooperative Groups
    Generic
    no links

    Active Hematology protocols         Study number links to NCI protocol site

    B-Cell Lymphoma

    • H6Q-MC-JCBJ - PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin

    Mantle Cell Lymphoma

    • N038H - Phase II Study of CCI-779 and Rituximab in Patients With Relapsed or Refractory Mantle Cell Lymphoma

    Non-Hodgkins Lymphoma

    • E4402 - Phase III Randomized Study of Rituximab in Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma
    Page updated: February 23, 2008
    Page top
    • Prospective Students
    • Admission
    • Academics
    • Campus Life
    • Current Students
    • Faculty & Staff
    • Research
    • Athletics
    • Alumni & Community
    The University of Toledo • 2801 W. Bancroft • Toledo, OH 43606-3390 • 1.800.586.5336
    © 2006-2008 The University of Toledo. All rights reserved. • Send all feedback / comments to webmaster.
    • Terms of Use